Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2024 · 10-Q
Revenue$69.46M$69.46M+10.0% vs Q2 2023 Net Income$715.00K$715.00K−75.2% vs Q2 2023 EPS Diluted$0.03$0.03−78.6% vs Q2 2023 Gross Profit$21,256,000+5.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived-$777,000N/M Free Cash Flowderived-$1,761,000N/M Margins · derivedGross margin30.6%−1.3 pt vs Q2 2023
Operating margin1.3%−4.6 pt vs Q2 2023
Net margin1.0%−3.5 pt vs Q2 2023
ended Sep 30, 2023 · filed Oct 31, 2023 · 31 d after period end